Clinical trial NCT02584036: Project IMPACT Immunizations (IMProving America's Communities Together)
Official title: Project IMPACT Immunizations (IMProving America's Communities Together)
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Influenza
Keywords: influenza
vaccine
public health
preventable disease
vaccine history
point-of-care
Lead sponsor: American Pharmacists Association Foundation
Sponsor class: OTHER
First posted: 2015-10-22
Enrollment: 1080
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Patients receiving an influenza vaccine

Brief summary: The primary objective of this study is to evaluate how implementing an innovative care model that provides the pharmacist access to a patient's vaccine history at the point-of-care impacts the pharmacist's ability to identify unmet vaccination needs and increase vaccination rates for routinely recommended adult vaccinations.

Detailed description: This is a multi-site, observational study investigating the impact of implementing an innovative care model on the pharmacist's ability to identify unmet vaccination needs and increase vaccination rates for routinely recommended adult vaccinations. The innovative care model enables the pharmacist to utilize a bi-directional IIS to assess patients' vaccination histories, identify unmet vaccination needs, and document the care provided. Data will be collected in the bi-directional IIS. Aggregate de-identified data will be reported to the researchers at the midpoint and conclusion of the study. The project duration has been established to allow sufficient time for each pharmacy to implement the innovative care model and monitor each pharmacy for a 6-month study period. The American Pharmacists Association (APhA) Foundation has an a priori intent to publish the project results.

Eligibility criteria: Inclusion Criteria:

* Individuals eligible to be enrolled in the study include any person at least 18 years of age receiving an influenza vaccination from a participating pharmacy site.

Exclusion Criteria:

* n/a

Primary outcomes:
measure: Number and types of vaccines administered
timeFrame: Change from baseline rates at 6 months
measure: Number of unmet vaccination needs identified and met
timeFrame: through study completion, an average of 6 months
measure: Number of times the pharmacist reviewed the vaccination forecast and educated the patient on his/her vaccine needs
timeFrame: through study completion, an average of 6 months
Secondary outcomes:
Other outcomes:
Locations:
city: Belfair
country: United States
facility: Quality Food Centers #101
state: Washington
city: Cheney
country: United States
facility: Cheney-Owl Pharmacy
state: Washington
city: Eatonville
country: United States
facility: Kirk's Pharmacy
state: Washington
city: Edmonds
country: United States
facility: Quality Food Centers #851
state: Washington
city: Lopez Island
country: United States
facility: Lopez Island Pharmacy
state: Washington
city: Seattle
country: United States
facility: Kelley-Ross Pharmacy
state: Washington
city: Spokane
country: United States
facility: ReliantRx
state: Washington
city: Yakima
country: United States
facility: Tieton Village Drug
state: Washington
Study officials:
affiliation: American Pharmacists Association
name: Benjamin M Bluml, BPharm
role: PRINCIPAL_INVESTIGATOR
References: